318 results on '"Occult malignancy"'
Search Results
2. CT imaging for occult malignancy in patients with unprovoked venous thromboembolism (VTE) in a tertiary centre: is it worthwhile?
- Author
-
Lee, Ronan J., Herlihy, Darragh, O'Neill, Damien C., Madden-Doyle, Lauren, Morrin, Martina, and Lee, Michael J.
- Abstract
Background: Investigating patients with unprovoked venous thromboembolism (uVTE) for occult malignancy can prove a diagnostic dilemma and imaging is often used extensively in this patient group. Aims: The primary objective of this study was to determine the incidence of malignancy on CT and other imaging over a 10-year period. A secondary objective was to evaluate the role of laboratory and other non-imaging tests performed. Methods: A retrospective key word search of our hospital's imaging system was performed to identify patients with unprovoked DVT/PE over the last 10 years. All imaging, histology, endoscopy, laboratory tests, and clinical follow-up over 2 years were analysed. Patients with provoked VTE were excluded. Results: 150 patients had uVTE. 9 patients were diagnosed with occult malignancy by different investigations on index hospital admission (3 patients) or subsequently on clinical follow-up (6 patients). Mean age of patients was 62 years. 116 patients had CT body imaging. The incidence of malignancy diagnosed by initial CT imaging was 1.7% with a sensitivity of 22%, specificity 87%, and PPV 12.5%. Overall incidence of malignancy identified by imaging alone during the index hospital admission was 2%. Total incidence of malignancy including index admission and follow-up was 6%. Median time to cancer diagnosis was 12 months. Conclusion: CT imaging had a low yield for diagnosing malignancy. Extensive imaging strategies increase cost and radiation exposure without improving mortality. Clinical follow-up, history taking, and physical examination guiding appropriate investigations remain the best tool for unmasking occult malignancy in patients with uVTE. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Non-Hypertensives and Those with Normal Cholesterol Are More Likely to Have Concomitant Cancer amongst Patients with Ischemic Stroke: A Retrospective Cross-Sectional Registry-Based Study
- Author
-
Kendra Jing Ying Tang, Seyed Ehsan Saffari, Kaavya Narasimhalu, Kian Kheng Queck, and Deidre Anne De Silva
- Subjects
ischemic stroke ,cancer ,occult malignancy ,registries ,risk factors ,incidence ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Introduction: Patients with cancer are known to have an increased risk of ischemic stroke (IS) around the time of their diagnosis. However, there is a paucity of data in Asian populations, and as such, we aimed to determine cancer incidence rates and patterns in Asian IS patients as well as investigate the differences in vascular risk profile of IS patients with and without concomitant cancer. Methods: We conducted a retrospective cross-sectional study using data from the Singapore Stroke and Cancer registries. We defined cases as patients with IS and a cancer diagnosis 2 years before or after the index IS. Cancer incidence was determined using the same direct age-standardization method performed for the Singapore general population in the 2015 Singapore cancer report. Multivariable logistic regression was used to analyze differences in vascular risk factors. Results: Among 21,068 IS patients (mean age, 67.9 ± 13.3 years), 6.3% (1,330) were found to have concomitant cancer; 4.4% (935) had prior cancer while 1.8% (395) had cancer diagnoses within 2 years following IS. The cancer incidence among IS patients was 3,393 (95% confidence interval [CI], 1,937–4,849) per 100,000 person-years compared to 219–231 per 100,000 person-years in the general population. Older age (odds ratio [OR], 1.02 [95% CI, 1.01–1.02] per year), males (OR, 1.25 [95% CI, 1.11–1.41), Chinese ethnicity (OR, 1.61 [95% CI, 1.37–1.89]) and a lower prevalence of hypertension (OR, 0.84 [95% CI, 0.73–0.97)]), and hyperlipidemia (OR, 0.53 [95% CI, 0.45–0.62]) were independently associated with cancer-related IS. Conclusions: The age-standardized cancer incidence was 15 times higher in IS patients than the general population. IS patients with concomitant cancer were older and had a lower prevalence of vascular risk factors.
- Published
- 2023
- Full Text
- View/download PDF
4. Routine evaluation of tonsillectomy specimens: a cross-sectional survey of Canadian Otolaryngology: Head and Neck Surgeons
- Author
-
Alexi Kuhnow, Ahmed A. Al-Sayed, and Benjamin Taylor
- Subjects
Routine tonsillectomy ,Tonsillectomy specimen ,Occult malignancy ,Survey ,Clinical practice ,Otolaryngology ,Surgery ,RD1-811 - Abstract
Abstract Background Tonsillectomy is a commonly performed procedure in Canada. The rate of occult malignancy is rare in adult and pediatric populations. At present, no guidelines exist surrounding the need for routine histopathological evaluation of tonsil specimens when no malignancy is suspected. Methods We sent a confidential online survey to active members of the Canadian Society of Otolaryngology – Head and Neck Surgery (CSO-HNS) about their current tonsillectomy practice and beliefs surrounding the need for routine histopathological evaluation of tonsillectomy specimens when no malignancy is suspected. We used Opinio survey software for data collection and descriptive statistics. Results 95 participants completed our survey (response rate 19.3%). Most participants reported performing both adult and pediatric tonsillectomies. When no malignancy is suspected, participant responses were split between whether they send tonsil specimens in pediatrics only (4.2%), in adults only (31.6%), or not sending specimens (29.5%). Half of the participants reported that routinely sending specimens to rule out occult malignancy is an institutional policy. Approximately 75% of participants were in favour of removing this practice in both the pediatric and adult populations. Conclusion Eliminating the practice of automatically sending tonsil specimens for histopathological evaluation when no malignancy is suspected was supported by the majority of study participants. This is in keeping with Choosing Wisely, a campaign designed to facilitate conversations about unnecessary medical tests and procedures. Institutional change is likely required in order to alter this practice. Graphical Abstract
- Published
- 2022
- Full Text
- View/download PDF
5. Colorectal Carcinoma in the Background of Pelvic Inflammatory Disease.
- Author
-
Kalas, M Ammar, Alhariri, Sara, Ortega, Andrew Jonathen, Galura, Gian Marco, Al Bayati, Ihsan, and Al Obaidi, Sarah
- Abstract
Colorectal carcinoma (CRC) is a common malignancy with steadily declining incidence rates and mortality, secondary to improved screening and lifestyle changes (eg, decreased smoking rates). The association between pelvic inflammatory disease (PID) and CRC has been unclear in the past. However, multiple studies showed a positive association between PID and underlying malignancy (gynecologic and pelvic primarily). Several studies evaluated the relation between PID and CRC, but the results were conflicting. We describe a case of a 33-year-old female patient, with a history of PID and recurrent pelvic abscesses, who was found to have CRC. Of note, the patient's diagnosis was based on abnormal computed tomography findings, which were further investigated (by colonoscopy and biopsy), rather than on symptoms suggestive of CRC, such as rectal bleeding, constipation, symptomatic anemia, or abdominal pain. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Mantle Cell Lymphona Masquerading as Obstructive Sleep Apnoea.
- Author
-
Ishak, Noor Liza, Tan Sui Teng, and Mahat, Mahfida
- Subjects
- *
SLEEP apnea syndromes , *TONSILLITIS , *MANTLE cell lymphoma , *CONTINUOUS positive airway pressure , *PATIENT compliance - Abstract
Tonsillar malignancy typically presents with asymmetrical tonsillar enlargement, lesion on the tonsils, sore throat or a neck mass. We report a case of unsuspected tonsillar malignancy in a 56-year-old gentleman who presented with symptoms of obstructive sleep apnoea. His tonsils were grade III bilaterally with normal mucosa. Tonsillectomy was performed to improve patient's compliance with Continuous Positive Airway Pressure (CPAP) therapy. These tonsillar specimens were reported to be Mantle Cell Lymphoma (MCL) based on the histology and ancillary studies. This case highlights that benign-looking symmetrical tonsillar enlargement can harbour occult malignancy. It is important to note that OSA symptoms may be the presentation for haematological malignancies. Tonsillar specimens should be sent for histopathological examination regardless of the indication to avoid misdiagnosis and delay in treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Routine evaluation of tonsillectomy specimens: a cross-sectional survey of Canadian Otolaryngology: Head and Neck Surgeons.
- Author
-
Kuhnow, Alexi, Al-Sayed, Ahmed A., and Taylor, Benjamin
- Subjects
- *
NECK surgery , *HEAD surgery , *OTOLARYNGOLOGISTS , *BIOLOGICAL products , *CROSS-sectional method , *PHYSICIANS' attitudes , *PEDIATRICS , *TONSILLECTOMY , *DESCRIPTIVE statistics , *DECISION making , *HISTOLOGY , *MEDICAL practice , *DATA analysis software , *MANAGEMENT , *OTOLARYNGOLOGY , *TONSILS - Abstract
Background: Tonsillectomy is a commonly performed procedure in Canada. The rate of occult malignancy is rare in adult and pediatric populations. At present, no guidelines exist surrounding the need for routine histopathological evaluation of tonsil specimens when no malignancy is suspected. Methods: We sent a confidential online survey to active members of the Canadian Society of Otolaryngology – Head and Neck Surgery (CSO-HNS) about their current tonsillectomy practice and beliefs surrounding the need for routine histopathological evaluation of tonsillectomy specimens when no malignancy is suspected. We used Opinio survey software for data collection and descriptive statistics. Results: 95 participants completed our survey (response rate 19.3%). Most participants reported performing both adult and pediatric tonsillectomies. When no malignancy is suspected, participant responses were split between whether they send tonsil specimens in pediatrics only (4.2%), in adults only (31.6%), or not sending specimens (29.5%). Half of the participants reported that routinely sending specimens to rule out occult malignancy is an institutional policy. Approximately 75% of participants were in favour of removing this practice in both the pediatric and adult populations. Conclusion: Eliminating the practice of automatically sending tonsil specimens for histopathological evaluation when no malignancy is suspected was supported by the majority of study participants. This is in keeping with Choosing Wisely, a campaign designed to facilitate conversations about unnecessary medical tests and procedures. Institutional change is likely required in order to alter this practice. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Primary vaginal adenocarcinoma of intestinal type or occult metastatic colon cancer: a diagnostic dilemma from a vaginal skin tag
- Author
-
Russell AL, Haagsma B, and Madhuri TK
- Subjects
Skin tag ,vaginal cancer ,metastases ,occult malignancy ,colon cancer ,Gynecology and obstetrics ,RG1-991 - Abstract
Anna Louise Russell,1 Ben Haagsma,2 Thumuluru Kavitha Madhuri3,4 1Department of Gynae-Oncology, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK; 2Department of Histopathology, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK; 3Department of Gynaecological Oncology, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK; 4Department of Experimental Medicine, Faculty of Health & Medical Sciences, University of Surrey, Guildford, UK Abstract: The presentation of a new vaginal lesion could represent a variety of diagnoses from benign warts to more sinister primary malignancies. Rarely, a new lesion could represent a metastatic deposit from a malignancy elsewhere in the body. Colonic carcinomas are the third most common malignancy, frequently metastasising to the liver and lung. There have been a small number of cases in the literature reporting vaginal metastases from colonic carcinoma and this is usually indicative of advanced disseminated disease. We present an interesting case of a 65-year-old female with a strong family history of bowel cancer who originally presented with a vaginal skin tag that was biopsied and found to be a moderately differentiated adenocarcinoma. The immunohistochemistry profile was cytokeratin (CK) 20 positive/CK 7 negative, highly suggestive of a bowel cancer primary. However, subsequent extensive radiological and endoscopic investigations failed to identify a colonic primary tumor. The vaginal lesion was successfully excised, and no systemic treatments were warranted. To date, no primary cancer has been identified; the patient remains asymptomatic with no clinical signs of disease recurrence 5 years following her initial diagnosis. This case represents a diagnostic dilemma between two very rare diagnoses of either a vaginal metastasis from an occult colonic primary tumor or a primary vaginal adenocarcinoma of endometrioid morphology demonstrating intestinal immunophenotype. Organizing colonic screening is recommended in view of the high risk of colonic adenocarcinoma. Keywords: skin tag, vaginal cancer, metastases, occult malignancy, colon cancer, villiform, intestinal villiform, endometrioid
- Published
- 2019
9. Occult Malignancy in Adult Tonsillectomy for Benign Indication.
- Author
-
Syme, Noah, Brettfeld, Stefan, Dorneden, Ashley, Samedi, Von, Bocklage, Therese, Myers, Orrin, Herzon, Fred, and Meiklejohn, Duncan A.
- Subjects
- *
ACQUISITION of data methodology , *RETROSPECTIVE studies , *TONSILLECTOMY , *MEDICAL records - Abstract
Objective: National pathology guidelines recommend full pathologic analysis for all adult tonsillectomy specimens. We evaluated the available data on occult malignancy in adult tonsillectomy for benign indication, and created a screening system to reduce the risk of missed malignancies if routine histopathologic examination were to be discontinued. Study design: Retrospective chart review and systematic review of the literature. Setting: Tertiary care academic hospital and multi-hospital private healthcare system. Subjects and methods: A systematic literature review identified case series of adult tonsillectomy. Retrospective chart review at our institutions from 2000 to 2016 produced an additional case series. The pooled rate of occult malignancy was determined, and re-analyzed using criteria based on preoperative risk factors designed to identify patients requiring full pathologic analysis. The predicted effects of prospective application of the proposed criteria were calculated. Pooled occult malignancy prevalence was estimated. Results: Literature review and our own case series yielded 12,094 total cases. Occult malignancy prevalence in the combined data was 0.033%, representing four occult malignancies. Three out of the four would have been selected for full pathology preoperatively with use of the proposed criteria. Statistical analysis indicates that the predicted frequency of occult malignancy incidence in cases negative for the criteria is 0.01%, or 1/10,000. Conclusion: Application of the proposed criteria to adults undergoing tonsillectomy for benign indication identifies a subset of patients with an estimated incidence of occult malignancy similar to that reported for pediatric tonsillectomy, and potentially may permit safe elimination of pathologic analysis of their tonsil specimens. Level of Evidence: Pooled analysis of case series from the literature and a single institution, level 4. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Occult Uterine Malignancy at the Time of Sacrocolpopexy in the Context of the Safety Communication on Power Morcellation by the FDA.
- Author
-
Chang, Olivia H. and Ferrando, Cecile A.
- Abstract
Study Objective: The objective of this study was to determine the incidence of occult uterine malignancy at the time of sacrocolpopexy with concurrent hysterectomy, in the context of practice pattern changes as a result of the 2014 Food and Drug Administration (FDA) power morcellation safety communication.Design: Retrospective chart review.Setting: Tertiary care referral center in the United States.Patients: A total of 839 patients who underwent sacrocolpopexy from January 2004 to December 2018.Interventions: All patients received a concurrent hysterectomy without a diagnosis of suspected or confirmed gynecologic malignancy before surgery. Trends of surgeries were compared before and after the 2014 FDA power morcellation safety communication.Measurements and Main Results: Demographic and perioperative data were collected from the system-wide electronic medical record. Operative and pathology reports were reviewed to determine the method of specimen retrieval and specimen pathology results. A total of 238 patients (28.4%) had a hysterectomy at the time of sacrocolpopexy. There were no cases of occult uterine malignancy (0%, 95% CI 0%-1.6%). There was 1 case of borderline tumor of the ovary. The most common mode of hysterectomy over the 15-year period was laparoscopic hysterectomy (n = 84, 35.3%), followed by vaginal hysterectomy (n = 63, 26.5%). After the FDA communication, the most common form of hysterectomy changed significantly to vaginal hysterectomy (n = 35, 55.6%; p <.001). When comparing the first 2 years after the announcement (2014-2016) to the subsequent 2 years (2017-2018), there was again a significant increase in the use of laparoscopic hysterectomy in the latter time period (7.3% vs 40.9%; p <.001).Conclusion: In this cohort of patients undergoing sacrocolpopexy with concurrent hysterectomy, the incidence of occult uterine malignancy was low. After the FDA safety communication, practice patterns with regard to the mode of hysterectomy changed, but the magnitude of these changes were transient. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
11. Increased LDH5/LDH1 ratio in preoperative diagnosis of uterine sarcoma with inconclusive MRI and LDH total activity but suggestive CT scan: a case report
- Author
-
Antonio Mollo, Antonio Raffone, Antonio Travaglino, Annalisa Di Cello, Gabriele Saccone, Fulvio Zullo, and Giuseppe De Placido
- Subjects
Fibroid ,LDH isoforms ,Serum markers ,Occult malignancy ,Surgical approach ,Choice of therapy ,Gynecology and obstetrics ,RG1-991 ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Morcellation of undiagnosed uterine sarcoma is cause of abdominal/pelvic dissemination, residual tumor and recurrence. In the preoperative evaluation of suspect uterine masses, magnetic resonance imaging (MRI) and serum lactate dehydrogenase (LDH) total activity are referred to as the most effective tools, while computed tomography scan (CT) and LDH isoenzymes are less considered in literature. Case presentation A 46 year old woman was admitted to our department with a large uterine mass. Ultrasonography, MRI and LDH total activity did not allow a diagnosis of malignancy, and the woman expressed the wish to avoid hysterectomy. In spite of this, we opted for a total abdominal hysterectomy instead of a laparoscopic myomectomy, due to an elevation of LDH5/LDH1 ratio and CT findings indicative of sarcoma. Histological examination revealed a high grade leiomyosarcoma, confirming our suspicion. Thus, we had avoided the risks linked to morcellation. Conclusions Our experience suggests that LDH isoenzymes assessment may be relevant in preoperative diagnosis of uterine sarcoma. Further studies are necessary to determine its role in a diagnostic algorithm. We think it may be useful especially for patients with clinical or ultrasonographic suspicion of uterine sarcoma not confirmed by imaging techniques. Furthermore, the role of less considered imaging techniques, such as CT, should not be underestimated in challenging cases.
- Published
- 2018
- Full Text
- View/download PDF
12. Prevalence of Occult Cancer in Acute Unprovoked Lower Extremities Deep Vein Thrombosis in Thai Patients.
- Author
-
Pruekprasert, K., Banthawatanarak, K., Ruangsetakit, C., Wongwanit, C., Chinsakchai, K., Hahtapornsawan, S., Hongku, K., Puangpanngam, N., and Sermsathanasawadi, N.
- Subjects
LEG ,BLOOD testing ,TUMOR markers ,BIOMARKERS - Abstract
Objective: To determine the prevalence of occult malignancy in Thai patients with the first episode of unprovoked deep vein thrombosis, and to identify the methods leading to the diagnosis of occult cancer. Materials and Methods: The medical records of 369 consecutive patients with symptomatic proximal DVT of the lower extremity were retrospectively reviewed. The patients' demographic data, sites of occult cancer, and the screening methods utilized for the detection of occult cancer were recorded. Results: Among the 369 acute DVT patients enrolled in this study, there were 104 (28.2%) unprovoked DVT cases, 106 (28.7%) DVT provoked by transient risk factors, and 159 (43.1%) cancer-associated DVT. Among the 104 patients with unprovoked DVT, occult malignancies were identified in 26 (25%) patients, with 13 (50.0%) of the occult cancers being in the metastatic stage. The methods leading to the diagnosis of occult cancers were limited screening by history taking and physical examination with a routine blood test and chest x-rays in 21 (80.8%) patients, by serum tumor markers screening in 3 (11.5%) patients, and by abdominal computed tomography screening in 2 (7.7%) patients. Conclusion: The prevalence of occult cancer in acute unprovoked DVT in the present study was 25%, with most of the occult cancers detected by a limited screening strategy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
13. Incidence of Leiomyosarcoma at Surgery for Presumed Uterine Myomas in Different Age Groups.
- Author
-
Rey Valzacchi, Guido M., Rosas, Patricio, Uzal, Mariano, Gil, Santiago J., and Viglierchio, Victorio T.
- Abstract
Study Objective: To evaluate the incidence of leiomyosarcoma (LMS) at surgery for presumed uterine myomas according to different age groups.Design: A retrospective cohort study.Setting: A tertiary referral hospital.Patients: All women undergoing surgery for presumed uterine myomas between January 1, 2006, and December 31, 2016.Interventions: Laparoscopic myomectomy, laparotomic myomectomy, total hysterectomy, or hysteroscopic myomectomy.Measurements and Main Results: A total of 1398 patients underwent surgery for presumed uterine myomas. The incidence of LMS was 2.15 per 1000 surgeries (n = 3, 1/466, 0.2%). In women under 40 years old, the incidence of occult LMS was 0 (0/561). In women between 40 and 49 years old, 190 myomectomies were performed (28% of the surgeries), and the rate of LMS was 1.49 per 1000 (n = 1, 1/673, 0.15%). In women over 49 years old, a total hysterectomy was performed in 82.3% of the cases, and the incidence of LMS was 12.2 per 1000 surgeries (n = 2, 1/82, 1.2%).Conclusion: The incidence of occult LMS in patients under 40 years old undergoing surgery for presumed uterine myomas was 0. These findings are suggestive that the use of power morcellation in this population may be safe. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
14. Massive left ventricular thrombosis in pericardial decompression syndrome.
- Author
-
Curiale, Andrew, Vallabhaneni, Srilakshmi, Longo, Santo, and Shirani, Jamshid
- Subjects
- *
THROMBOSIS diagnosis , *THROMBOLYTIC therapy , *LEFT heart ventricle , *PERICARDIAL effusion , *SURGICAL complications , *ANTICOAGULANTS , *CARDIAC tamponade , *TREATMENT effectiveness - Abstract
Background: Pericardial decompression syndrome (PDS) is defined as paradoxical hemodynamic deterioration associated with left, right, or bi‐ventricular dilation and systolic dysfunction following pericardiocentesis. It is uncommon yet under‐recognized, underreported, and associated with significant morbidity and mortality. Case report: We report a unique case of PDS associated with left ventricular (LV) systolic dysfunction and massive apical thrombosis following surgical removal of 800 ml of pericardial fluid in a 72‐year‐old man with undiagnosed lung cancer. Treatment with anticoagulation and anti‐remodeling medications resulted in complete resolution of the thrombus and recovery of LV function. Conclusions: PDS, although rare, can lead to significant morbidity and mortality. Left ventricular apical thrombosis could result from PDS in the setting of hypercoagulable state. Treatment of the underlying disease may lead to successful resolution of PDS and its complications. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
15. Occult malignancy in pediatric tonsil and adenoid surgeries – A national survey.
- Author
-
Lifshitz, Guy, Gruber, Maayan, and Ronen, Ohad
- Subjects
- *
ADENOIDECTOMY , *PEDIATRIC surgery , *TONSILLECTOMY , *ADENOIDS , *TONSILS , *BURKITT'S lymphoma , *ADENOID cystic carcinoma , *MEDICAL centers - Abstract
Abstract Objective To evaluate the incidence of tonsil and adenoid malignancy in pediatric patients in Israel compared to the known literature and to revisit the common practice of routine histopathologic examination of tonsils and adenoids. Methods Analysis of the Israel National Cancer Registry data on pediatric tonsil and adenoid malignancies between the years 2005 and 2015, and a systematic literature review of all relevant articles that reported on malignancies amongst pediatric patients who underwent tonsillectomy with or without adenoidectomy. Results Only seven cases of tonsillar malignancies were documented out of 152,352 (0.0052%) surgeries in the pediatric population. All malignancies were lymphoproliferative and mainly Burkitt's lymphoma. In our medical center no malignancy was found in 2165 patients in the same age groups and time period. We found the incidence of tonsillar malignancy in Israel to be significantly lower (p = 0.013) compared to the previously described literature. Conclusion The incidence of malignancy in routine histopathological examination of tonsils and adenoids is Israel is very low when compared to the known literature. According to these results, we suggest that routine histopathological examination of all such samples is not clinically justified. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
16. Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists.
- Author
-
Blustein, Pegah, Werner, Sarah R., Uppalapati, Pooja, Leung, Tung Ming, Husk, Gregg A., Pereira, Elena B., Whyte, Jill S., and Villella, Jeannine A.
- Subjects
BRCA genes ,GYNECOLOGISTS ,ONCOLOGISTS ,SALPINGO-oophorectomy ,GYNECOLOGIC care ,SALPINGECTOMY ,HYSTERO-oophorectomy - Abstract
Risk-reducing bilateral salpingo-oophorectomy reduces mortality from high-grade serous carcinoma in patients with hereditary breast and ovarian cancer associated gene mutations. Ideal surgical management includes 5 steps outlined in 2005 by the Society of Gynecologic Oncology and the American College of Obstetricians and Gynecologists. In addition, it is recommended that pathologic examination include serial sectioning of specimens. In practice, risk-reducing salpingo-oophorectomy is performed by both gynecologic oncologists and general gynecologists. To ensure optimal detection of occult malignancy, standardized adherence to outlined guidelines is necessary. This study aimed to evaluate the adherence to optimal surgical and pathologic examination guidelines and to compare the rate of occult malignancy at the time of surgery between 2 provider types. Institutional review board exemption was obtained. A retrospective review of patients undergoing risk-reducing bilateral salpingo-oophorectomy without hysterectomy from October 1, 2015, to December 31, 2020, at 3 sites within a healthcare system was conducted. The inclusion criteria included age ≥18 years and a documented indication for surgery being a mutation in BRCA1 or BRCA2 or a strong family history of breast and/or ovarian cancer. Compliance with 5 surgical steps and pathologic specimen preparation was based on medical record documentation. Multivariable logistic regression was used to determine differences in adherence between provider groups and surgical and pathologic examination guidelines. A P value of <.025 was considered statistically significant for the 2 primary outcomes after Bonferroni correction was applied to adjust for multiple comparisons. A total of 185 patients were included. Among the 96 cases performed by gynecologic oncologists, 69 (72%) performed all 5 steps of surgery, 22 (23%) performed 4 steps, 5 (5%) performed 3 steps, and none performed 1 or 2 steps. Among the 89 cases performed by general gynecologists, 4 (5%) performed all 5 steps, 33 (37%) performed 4 steps, 38 (43%) performed 3 steps, 13 (15%) performed 2 steps, and 1 (1%) performed 1 step. Gynecologic oncologists were more likely to document adherence to all 5 recommended surgical steps in their surgical dictation (odds ratio, 54.3; 95% confidence interval, 18.1–162.7; P <.0001). Among the 96 cases documented by gynecologic oncologists, 41 (43%) had serial sectioning of all specimens performed, compared with 23 of 89 cases (26%) performed by general gynecologists. No difference in adherence to pathologic guidelines was identified between the 2 provider groups (P =.0489; note: P value of >.025). Overall, 5 patients (2.70%) had occult malignancy diagnosed at the time of risk-reducing surgery, with all surgeries performed by general gynecologists. Our results demonstrated greater compliance with surgical guidelines for risk-reducing bilateral salpingo-oophorectomy in gynecologic oncologists than in general gynecologists. No considerable difference was determined between the 2 provider types in adherence to pathologic guidelines. Our findings demonstrated a need for institution-wide protocol education and implementation of standardized nomenclature to ensure provider adherence to evidence-based guidelines. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Unilateral Arm Urticaria Presenting as a Paraneoplastic Manifestation of Metachronous Bilateral Breast Cancer
- Author
-
Pashtoon Murtaza Kasi, Tina J. Hieken, and Tufia C. Haddad
- Subjects
Rash ,Adenocarcinoma ,Paraneoplastic syndromes ,Urticaria ,Dermatological symptoms ,Neurological complications ,Breast cancer ,Occult malignancy ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Various paraneoplastic syndromes (PNS) are reported to be associated with breast cancer and can range from mild dermatological symptoms to severe neurological complications. Neurological and dermatological manifestations tend to be the more commonly seen paraneoplastic manifestations, albeit both are relatively rare. Diagnosis of the underlying malignancy is often delayed since the presence and severity of paraneoplastic manifestations are not dependent on the tumor size or stage. Herein, we describe a unique case of unilateral arm urticaria presenting as a paraneoplastic manifestation of metachronous bilateral breast cancer. Similar reports and other PNS associated with breast cancer are described. Recognition of PNS associated with underlying malignancies and age-appropriate screening can facilitate diagnosis of the underlying occult malignancy. Resection of the underlying malignancy can lead to resolution and/or improvement of the PNS for some patients.
- Published
- 2016
- Full Text
- View/download PDF
18. Lymphocytic Effusions
- Author
-
Ali, Syed Z., Cibas, Edmund S., Ali, Syed Z., and Cibas, Edmund S.
- Published
- 2012
- Full Text
- View/download PDF
19. Nodal Metastases in Nasal Squamous Carcinoma
- Author
-
Rambaldi, Pier Francesco and Rambaldi, Pier Francesco
- Published
- 2014
- Full Text
- View/download PDF
20. Recurrent Multifocal Embolic Strokes in a 50-Year-Old Male: Unmasking Occult Squamous Cell Carcinoma.
- Author
-
Prabakar D, Sabesan V, Emenogu OP, and Mai C
- Abstract
Recurrent cryptogenic embolic strokes pose a diagnostic challenge, often necessitating an extensive evaluation to determine the underlying cause. Cancer-related stroke is a frequently overlooked etiology, accounting for a substantial proportion of cryptogenic strokes. This case study underscores the importance of considering occult malignancies in patients with recurrent strokes of unknown origin and emphasizes the need for a comprehensive diagnostic workup to detect hidden malignancies. A 50-year-old male with a complex medical history presented with expressive aphasia and blurred vision resembling previous stroke episodes. Neurological examinations revealed right hemianopsia, paraphasia, and abnormal coordination. Neuroimaging studies showed multiple chronic infarctions, a large hemorrhagic infarction in the left posterior cerebral artery territory, and a small acute-to-subacute left parietal infarction. Due to the time of presentation and the presence of hemorrhagic transformation, the patient did not meet the criteria for intravenous tissue plasminogen activator administration. Given the recurrent nature of the strokes, an extensive evaluation was initiated to determine the underlying cause. Vascular imaging, including magnetic resonance angiography (MRA) of the head and neck and a CT angiogram, showed no significant stenosis. Vasculitis workup and cardiac evaluation yielded negative results. The blood workup was notable for elevated D-dimer levels. The involvement of multiple vascular territories and recurrent stroke despite adequate treatment and the absence of traditional risk factors for stroke raised a high clinical suspicion of occult malignancy. Further investigations led to the diagnosis of locally advanced squamous cell carcinoma (P16+), metastatic to the right neck lymph nodes (cTxN3M0). Although the primary source of cancer could not be identified, the P16+ status suggests the right tonsil or base of the tongue as the probable origin. Anticoagulation therapy was initiated, and the patient was scheduled for chemoradiation therapy. Although routine cancer investigation is not justified in ischemic strokes, the possibility of an occult malignancy should be considered in the presence of multifocal infarctions across different vascular territories with elevated D-dimer levels, particularly when traditional risk factors have been ruled out. A detailed physical exam can help localize the malignancy and early identification of occult malignancies can guide appropriate management strategies and help prevent future strokes. Further clinical trials are needed to establish optimal therapeutic approaches for preventing stroke recurrence in cancer-related strokes., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2023, Prabakar et al.)
- Published
- 2023
- Full Text
- View/download PDF
21. Unexpected malignancy diagnosed in presumed symptomatic and asymptomatic endometrial polyps and submucosal myomas after hysteroscopic resection.
- Author
-
Gawron, Iwona and Ludwin, Artur
- Subjects
- *
ENDOMETRIAL hyperplasia , *ENDOMETRIAL cancer , *PRECANCEROUS conditions , *TRANSVAGINAL ultrasonography , *OVARIAN cancer , *UTERINE hemorrhage , *HIGH-intensity focused ultrasound , *PROGNOSIS - Abstract
Hysteroscopy is the treatment of choice of benign intrauterine conditions, whenever feasible. During hysteroscopic procedures performed with the intent of resecting myomas and polyps, there is a potential risk of an unexpected diagnosis of an occult malignant lesion. Objective: To estimate the incidence of occult uterine malignancy in women undergoing hysteroscopic electroresection due to a diagnosis of benign uterine lesions: endometrial polyps and submucosal myomas, by ultrasound. Material and methods: The electronic database of patients hospitalized between January 2010 and December 2016 in the Department of Gynecology and Oncology of the Jagiellonian University was searched for women who had undergone hysteroscopic surgery due to presumed endometrial polyps and submucosal myomas. Medical records of 1,006 eligible women were analyzed. Results: Ten cases (10/1,006; 1%) of occult endometrial cancer, 2 cases (2/1,006; 0,2%) of low-grade endometrial stromal sarcoma and 3 cases (3/1,006; 0,3%) of atypical endometrial hyperplasia were found postoperatively. One case of ovarian cancer coexisting with endometrial cancer was diagnosed. Of the factors analyzed, only age, menopausal status and abnormal uterine bleeding turned out to be significant endometrial cancer risk factors. Too few sarcoma cases did not allow similar estimates. We did not observe worsening of the prognosis, and all 15 patients who underwent hysteroscopic resection of the unforeseen malignancy or precancerous lesion are still alive within 2-8 years of follow-up. Conclusions: The incidence of unlooked-for malignancy in patients with benign intracavitary lesions, i.e. endometrial polyps and submucosal myomas, is relatively high. No negative effects of hysteroscopic resection on potential further treatment and prognosis have been proven so far. High risk of malignancy in women with presumed benign intracavitary lesions may indicate that not all these women are appropriate candidates for laparoscopic procedures with power morcellation, particularly when no previous histopathological verification is ordered. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
22. The incidence of occult malignancy following uterine morcellation: A ten-year single institution experience retrospective cohort study.
- Author
-
Mori, Kristina M., Abaid, Lisa N., Mendivil, Alberto A., IIIBrown, John V., Beck, Tiffany L., Micha, John P., Epstein, Howard D., Goldstein, Bram H., and Brown, John V 3rd
- Abstract
Introduction: When the Food and Drug Administration (FDA) initially reported on the parlous incidence (0.28%) of occult malignancy identified following uterine power morcellation, investigations thereafter documented their particular experience with this surgical procedure. Nevertheless, the precise risk of identifying a sarcoma following uterine morcellation remains indeterminate, primarily due to varying study patient risk factors, diagnostic criteria and operative approach.Method: We retrospectively evaluated subjects who underwent an endoscopic hysterectomy and uterine power morcellation for the treatment of a presumptive, benign indication from January 2006 until December 2015. The primary outcome was the incidence of an occult malignancy. Secondarily, we were interested in characterizing the patients' specific clinical (age, menopausal status, body mass index (BMI)) risk factors within the context of a confirmed malignant or pre-malignant pathology.Results: We identified 281 patients who underwent endoscopic surgery that incorporated uterine morcellation. During the study period, one subject was ultimately diagnosed with a uterine leiomyosarcoma; the overall incidence of occult malignancy was 0.36%. There were also 3 cases of uterine premalignant disease on final pathology (2 patients had complex hyperplasia with or without atypia and 1 subject was diagnosed with a smooth muscle tumor of uncertain malignant potential (an incidence of 1.1%)). We were unable to establish any relationship between patient age, uterine weight, menopausal status or BMI and the incidence of a malignant or pre-malignant pathology (P > 0.05).Conclusion: The rate of occult malignancy in the present investigation was similar to previously documented studies and that which has been reported by the FDA. Additional study of methods in which to enhance preoperative work-up and mitigate the surgical risk for tumor cell dissemination is warranted. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
23. Screening auf okkulte Neoplasien bei Patienten mit unprovozierter venöser Thromboembolie.
- Author
-
Šarinayová, Svetlana
- Abstract
Unprovoked venous thromboembolism (VTE) can be the first sign of cancer. In 5-10% of patients with unprovoked VTE, cancer is diagnosed in the twelve months following the event. After an unprovoked VTE diagnosis, patients should undergo a thorough medical history, careful physical examination, laboratory investigations (blood counts with blood smear, liver enzymes, calcium, and urinalysis) and chest X-ray. In addition, specific cancer screening (colon, cervix, breast, and prostate) should be performed according to age and sex. Any anomalies must be further investigated. So far, no study has been able to prove that extended screening could improve the rate of occult cancer detection or decrease cancer-related mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
24. Occult Malignancy Incidence and Preoperative Assessment in Hysterectomies with Morcellation.
- Author
-
Wilkie, Gianna L., Reus, Emily, Leung, Katherine, Bradford, Leslie, Manning, Mark J., and Moore Simas, Tiffany A.
- Subjects
- *
BIOPSY , *COMPUTED tomography , *DEMOGRAPHY , *ENDOSCOPIC surgery , *HYSTERECTOMY , *LONGITUDINAL method , *MAGNETIC resonance imaging , *WOMEN , *CANCER of unknown primary origin , *RETROSPECTIVE studies , *PREOPERATIVE period , *DILATATION & curettage - Abstract
Objective: The aims of this research were to quantify the incidence of malignancy in women undergoing hysterectomy for benign indications and to compare the preoperative evaluation of patients undergoing hysterectomy with and without morcellation. Materials and Methods: This retrospective cohort study identified women undergoing hysterectomies between October 2007 and June 2014. Chart abstraction included demographics; prehysterectomy evaluation, including current cervical cytology, pathologic endometrial assessment (biopsy, dilation and curettage [D&C]); and imaging (ultrasound, magnetic resonance imaging, computed tomography); intraoperative factors; and final pathology. Results: The analyzed cohort included 2309 women undergoing hysterectomy with 396 (17.1%) who had morcellation. Women undergoing hysterectomy with morcellation were, on average, younger, compared to those having hysterectomy without morcellation (33.4 ± 18.8 versus 39.7 ± 17.6; p < 0.001). The incidence of malignancy was 1.7% and was different between nonmorcellated versus morcellated specimens (2.0% versus 0.3%; p < 0.001). There was no significant difference in preoperative cervical cytology (68.9% versus 71.0%) and imaging (39.6% versus 35.2%) assessment rates between the nonmorcellated versus morcellated groups; however, patients who had morcellation were less likely to have had preoperative pathologic endometrial assessments (21.7% versus 34.1%; p < 0.001). Conclusions: The risk of occult malignancy noted during hysterectomy was low overall. Preoperative evaluation of patients undergoing hysterectomy with morcellation was similar to those without morcellation, except for lower rates of endometrial assessment by biopsy or D&C. Given the concern for possible dissemination of occult malignancy with morcellation, one may consider preoperative assessment with endometrial biopsy prior to surgery or contained morcellation. The cost-efficacy and clinical efficacy of this warrants further investigation. (J GYNECOL SURG 34:18) [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
25. Isolated Abducens Palsy Heralding Occult Human Immunodeficiency Virus–Related Lymphoma.
- Author
-
Baartman, Brandon J. and Adamopoulou, Chrysavgi
- Subjects
- *
DIAGNOSIS of HIV infections , *CEREBROSPINAL fluid , *LYMPHOMAS , *BRAIN imaging - Abstract
A 40-year-old African American man with recently diagnosed Human Immunodeficiency Virus (HIV) presented with isolated left abducens palsy. Initial neuro-imaging and laboratory evaluation, including cerebrospinal fluid (CSF) analysis, were unremarkable. Continued search for causative aetiology revealed systemic lymphoma diagnosed ultimately by bone marrow biopsy. Systemic lymphoma is commonly encountered in the HIV patient population, but presentation can be unusual and has been seen, albeit rarely, in the setting of isolated cranial neuropathy. This case demonstrates the often diligent investigation required in the setting of isolated cranial neuropathies in patients with HIV. [ABSTRACT FROM PUBLISHER]
- Published
- 2018
- Full Text
- View/download PDF
26. Internal Malignancy Associated with Dermatomyositis
- Author
-
Dourmishev, Lyubomir A. and Dourmishev, Assen L.
- Published
- 2009
- Full Text
- View/download PDF
27. Partial-Thickness Excision
- Author
-
Cataldo, Peter A. and Mortensen, Neil J.
- Published
- 2009
- Full Text
- View/download PDF
28. Occult adenocarcinoma in adenomas. Possibilities of diagnostic methods
- Subjects
medicine.diagnostic_test ,business.industry ,Optimal treatment ,medicine.medical_treatment ,Colonoscopy ,Mean age ,Rectal examination ,Microsurgery ,medicine.disease ,Occult ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,medicine ,Occult malignancy ,Adenocarcinoma ,030211 gastroenterology & hepatology ,business ,Nuclear medicine - Abstract
Aim: to analyze the diagnostic value of the digital rectal examination, colonoscopy, MRI and ERUS for detecting occult adenocarcinoma in rectal adenomas.Patients and methods: the study included 100 patients with newly identified epithelial rectal neoplasms, which undergone transanal endoscopic microsurgery from December 2019 to December 2020. All the patients underwent digital rectal examination, colonoscopy, ERUS with sonoelastography, and pelvic MRI. The diagnostics value of this methods was estimated with determination of sensitivity and specificity.Results: the study included 67 (67%) females and 33 (33%) males. The mean age of the patients was 64.4 ± 10.7 years. The median distance from the tumor to the anal verge was 6.0 ± 2.9 cm. The sensitivity of the digital rectal examination in the occult malignancy verification was 0.44 (95% CI 0.24–0.65), specificity — 0.93 (95% CI 0.85–0.97). The sensitivity of the colonoscopy — 0.56 (95% CI 0.34–0.75), the specificity — 0.84 (95% CI 0.73–0.91). The sensitivity of MRI — 0.40 (95% CI 0.21–0.61), specificity — 0.89 (95% CI 0.80–0.95). The sensitivity of ERUS was 0.48 (95% CI 0.27–0.68), the specificity — 0.73 (95% CI 0.61–0.82). Pair wise comparison of diagnostic methods revealed the absence of significant differences in their diagnostic value (p > 0.05).Conclusion: at least one of diagnostic methods allows to verify the presence of malignant transformation in 100% of cases. So, only combination of diagnostic methods can help to choose the optimal treatment option.
- Published
- 2021
29. 'Unresectable' polyp management utilizing advanced endoscopic techniques results in high rate of colon preservation
- Author
-
Carey J. Wickham, Sang W. Lee, Kasim L. Mirza, Erik R. Noren, Joongho Shin, Jennifer Wang, and Kyle G. Cologne
- Subjects
High rate ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Endoscopic mucosal resection ,Hepatology ,Benign polyps ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Internal medicine ,Propensity score matching ,medicine ,Occult malignancy ,030211 gastroenterology & hepatology ,business ,Colectomy ,Abdominal surgery - Abstract
“Endoscopically unresectable” benign polyps identified during screening colonoscopy are often referred for segmental colectomy. Application of advanced endoscopic techniques can increase endoscopic polyp resection, sparing patients the morbidity of colectomy. This retrospective case-control study aimed to evaluate the success of colon preserving resection of “endoscopically unresectable” benign polyps using advanced endoscopic techniques including endoscopic mucosal resection, endoscopic submucosal dissection, endoluminal surgical intervention, full-thickness laparo-endoscopic excision, and combined endo-laparoscopic resection. A prospectively maintained institutional database identified 95 patients referred for “endoscopically unresectable” benign polyps from 2015 to 2018. Cases were compared to 190 propensity score matched controls from the same database undergoing elective laparoscopic colectomy for other reasons. Primary outcome was rate of complete endoscopic polyp removal. Secondary outcomes included length of stay, unplanned 30-day readmission and reoperation, 30-day mortality, and post-procedural complications. Advanced endoscopic techniques achieved complete polyp removal without colectomy in 66 patients (70%). Failure was most commonly associated with previously attempted endoscopic resection and occult malignancy. Compared with matched colectomy controls, endoscopic polyp resection resulted in significantly shorter hospital length of stay (1.13 ± 2.41 vs 3.89 ± 4.57 days; p
- Published
- 2021
30. Incidence of lung cancer following pneumonia in smokers: a population-based study
- Author
-
Daniel Shepshelovich, A Zer, Talia Diker-Cohen, Ran D. Balicer, Noam Barda, Hadar Goldvaser, Noa Dagan, and Anat Gafter-Gvili
- Subjects
medicine.medical_specialty ,Lung Neoplasms ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Occult malignancy ,Humans ,Medicine ,030212 general & internal medicine ,Lung cancer ,Retrospective Studies ,Smokers ,business.industry ,Incidence ,Incidence (epidemiology) ,Pneumonia ,General Medicine ,Odds ratio ,medicine.disease ,respiratory tract diseases ,Population based study ,Radiological weapon ,Cohort ,business - Abstract
Summary Background Pneumonia is more common in smokers compared with non-smokers. A high 1-year prevalence of lung cancer following hospitalization for pneumonia was demonstrated in heavy smokers. Aim To assess the association between hospitalization for pneumonia among ever-smokers and subsequent lung cancer risk. Design Retrospective analysis. Methods The study cohort included all ever-smokers aged 55–80 hospitalized for pneumonia between the years 2010–15 covered by a large medical insurer in Israel. Controls were matched to cases by age in a 4:1 ratio. The primary outcome was the association between hospitalization for pneumonia and subsequent 1-year incidence of lung cancer, adjusted for gender, smoking status (past/current) and pack years. Pre-specified sensitivity analyses excluded heavy smokers (smoking history of more than 30 pack years) and patients diagnosed with lung cancer within 30 days of hospitalization, as they probably had clinical or radiological findings suggestive of lung cancer, making them ineligible for screening. Results Lung cancer was identified in 275 of 12 807 (2.1%) patients following hospitalization for pneumonia and in 44 of 51 228 (0.1%) controls (adjusted odds ratio 22.46, 95% CI 16.29–30.96, P Conclusions Hospitalization for pneumonia is associated with high 1-year incidence of lung cancer in ever-smokers, supporting the important role of the widely used practice of performing follow up imaging post-pneumonia to exclude occult malignancy.
- Published
- 2021
31. Extensive screening for occult malignancy in unprovoked venous thromboembolism: A meta-analysis.
- Author
-
Zhou, Min, Zhang, Liyong, Ding, Yong, Wang, Yonggang, Yan, Dong, Lin, Changpo, Shi, Zhenyu, and Fu, Weiguo
- Subjects
- *
THROMBOEMBOLISM , *META-analysis , *CANCER-related mortality , *COMPUTED tomography , *MEDICAL screening - Abstract
Background The present meta-analysis aimed to evaluate the efficacy and sensitivity of an extensive screening strategy for occult malignant diseases in patients with unprovoked venous thromboembolism (VTE). Methods We conducted a systematic search of PubMed, Cochrane, EMBASE, and relevant article references. Meta-analysis was used to pool weighted relative risks (RR) for the rate of missed diagnosis, all-cause mortality, and cancer-related mortality. Heterogeneity test was performed using the inconsistency index. Furthermore, pooled analysis of the sensitivity and the proportion of false-positive findings of PET/CT were conducted. Results A total of 5 controlled studies were included with 1,115 and 1,159 unprovoked VTE patients receiving limited or extensive screening strategy, respectively. The risk of missed diagnosis (RR, 0.51; 95% CI, 0.20–1.28; P = 0.15) was not significantly different between the limited and extensive screening group. Moreover, there was no statistically significant difference in all-cause mortality (RR, 0.86; 95% CI, 0.58–1.27; P = 0.44) and cancer-related mortality (RR, 0.86; 95% CI, 0.46–1.62; P = 0.65) between the two groups. The pooled sensitivity and proportion of false-positive findings of PET/CT as a screening tool for occult malignancy in patients with unprovoked VTE was 95% (95% CI, 38%–100%) and 33% (95% CI, 20%–47%), respectively. Conclusions Extensive screening strategy did not show a clinically significant benefit over limited screening strategy. Considering the high cost and the additional physical and emotional harm, current evidence did not support extensive screening for each patient in the setting. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
32. Stroke and cancer.
- Author
-
Zuber M
- Subjects
- Adult, Humans, Cerebral Hemorrhage drug therapy, Magnetic Resonance Imaging methods, Prognosis, Thrombolytic Therapy methods, Stroke diagnosis, Stroke epidemiology, Stroke etiology, Neoplasms complications, Neoplasms epidemiology, Neoplasms therapy, Brain Ischemia therapy
- Abstract
Association between stroke and cancer is well-established and has led to a growing literature over the past decades. Risk of ischemic and hemorrhagic stroke is increased among patients with newly diagnosed cancer and 5-10% of stroke patients bear an active cancer. All cancers are concerned, but hematological malignancy in childhood and adenocarcinoma from lung, digestive tract and pancreas in adults are most usually identified. Unique stroke mechanisms are dominated by hypercoagulation, a condition that may lead to both arterial and venous cerebral thromboembolism. Direct tumor effects, infections and therapies may also play some active role in stroke happening. Magnetic Resonance Imaging (MRI) is helpful in: i) detecting typical patterns of ischemic stroke in cancer patients (i.e. concomitant strokes in multiple arterial territories); ii) distinguishing spontaneous intracerebral hemorrhage from tumor bleeding. Recent literature suggests that acute treatment using intravenous thrombolysis is safe in non-metastatic cancer patients. First results from endovascular procedures are reassuring, although arterial reobstruction is more frequent than in cancer-free patients. Prognosis is worse in patients with compared to those without cancer and mostly depends upon several predictors such as the initial stroke severity and the presence of metastasis. In the present review, we aim to provide some practical responses to neurologists about the stroke-cancer association, including prevalence, stroke mechanisms, biomarkers indicative for an occult cancer, influence of neoplasia on acute and long-term stroke treatments, and prognosis., (Copyright © 2023 Elsevier Masson SAS. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
33. Sellar Metastases
- Author
-
Thiago Albonette-Felicio, Mostafa Shahein, Daniel M. Prevedello, and Ricardo L. Carrau
- Subjects
medicine.medical_specialty ,business.industry ,Usually asymptomatic ,General Medicine ,medicine.disease ,Primary lesion ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Pituitary adenoma ,030220 oncology & carcinogenesis ,Skull base surgery ,Occult malignancy ,Medicine ,Surgery ,Neurology (clinical) ,Radiology ,business ,030217 neurology & neurosurgery - Abstract
Sellar metastases account for 0.87% of all intracranial metastases. They are usually asymptomatic and can be the first manifestations of some occult malignancy. The diagnosis is made mainly during the screening of patients with known primary lesions or can present with neurologic or hormonal changes related to compression or invasion of surrounding structures. Differentiating these lesions from other more common lesions such as pituitary adenoma maybe difficult. Management is mainly aimed at the primary lesion and is palliative to improve quality of life or for pathologic confirmation.
- Published
- 2020
34. Optimal treatment of pseudoangiomatous stromal hyperplasia of the breast
- Author
-
Bonyong Koo, Jee Ye Kim, Kwang Hyun Yoon, Byeong Woo Park, Seho Park, Young Up Cho, Haemin Lee, Seung Il Kim, Hyung Seok Park, Jeea Lee, and Kwan Beom Lee
- Subjects
Adult ,Pseudoangiomatous stromal hyperplasia ,Angiomatosis ,medicine.medical_specialty ,Adolescent ,lcsh:Surgery ,Physical examination ,030230 surgery ,Pseudoangiomatous stromal hyperplasia of the breast ,Lesion ,Breast Diseases ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Surgical procedures ,Biopsy ,medicine ,Clinical endpoint ,Occult malignancy ,Humans ,Breast ,Monitoring, Physiologic ,Hyperplasia ,medicine.diagnostic_test ,business.industry ,Optimal treatment ,lcsh:RD1-811 ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,030220 oncology & carcinogenesis ,Disease Progression ,Core needle biopsy ,Female ,Surgery ,Biopsy, Large-Core Needle ,Radiology ,Palpable mass ,medicine.symptom ,business ,Follow-Up Studies - Abstract
Summary Background Pseudoangiomatous stromal hyperplasia (PASH) is a benign mesenchymal proliferative lesion of the breast. Owing to the rarity of PASH, the pathogenesis, clinical manifestation, and optimal treatment of this condition remain unclear. We aimed to clarify the appropriate management of PASH. Methods We performed a retrospective analysis of the clinicopathological data of 66 cases with a diagnosis of PASH, confirmed by core needle biopsy (CNB) or surgical excision at Severance Hospital between 2000 and 2016. The primary endpoint was pathologic results after surgical excision of the lesion that confirmed PASH by CNB. The secondary endpoint was progression after the first treatment. Result The median age of patients was 41 years (range, 14–61 years). Findings on medical imaging were nonspecific. CNB was performed in 61 cases, with a diagnosis of PASH confirmed in 39 cases (63.9%). No malignant or premalignant cells directly arising from PASH were identified after surgical excision that confirmed PASH via CNB. The progression rate after the first treatment was 16.6%, with lesion size, enlargement of palpable mass size, and a diagnosis other than PASH on CNB being factors associated with progression. Conclusion CNB is sufficient to confirm PASH what is necessary for an abnormal imaging or suspicious physical examination finding. Surgical excision is not necessarily indicated to rule out occult malignancy after a diagnosis of PASH. Close monitoring or surgical excision are required to manage large lesions (>3 cm) or progressive growth of a PASH lesion.
- Published
- 2020
35. Preventing organ injury and dissemination of an occult malignancy and benign gynecologic disease during vaginal morcellation with a large uterus in laparoscopic hysterectomy
- Author
-
Akiyoshi Yamanaka, Makiko So, Masataka Nakajima, Kentaro Ishida, Michikazu Nagura, Atsushi Murakami, and Maki Umemiya
- Subjects
medicine.medical_specialty ,business.industry ,General surgery ,Laparoscopic hysterectomy ,medicine ,Occult malignancy ,General Earth and Planetary Sciences ,Disease ,business ,Large uterus ,General Environmental Science - Published
- 2020
36. Acquired perforating dermatosis: clinicopathologic study of a 10‐year period at a tertiary teaching hospital
- Author
-
Paulo Filipe, Catarina Soares Queirós, Pedro Garrido, Luís Soares-Almeida, João Borges-Costa, and Repositório da Universidade de Lisboa
- Subjects
Adult ,Male ,medicine.medical_specialty ,Systemic disease ,Acquired perforating dermatosis ,Histamine Antagonists ,Dermatology ,Severity of Illness Index ,Skin Diseases ,Teaching hospital ,Acitretin ,Tertiary Care Centers ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Neoplasms ,Diabetes mellitus ,Diabetes Mellitus ,medicine ,Occult malignancy ,Humans ,Renal Insufficiency, Chronic ,Hospitals, Teaching ,Glucocorticoids ,Aged ,Retrospective Studies ,Skin ,Aged, 80 and over ,Portugal ,business.industry ,Mental Disorders ,Retrospective cohort study ,Middle Aged ,Phototherapy ,medicine.disease ,Treatment Outcome ,Lower Extremity ,Virus Diseases ,030220 oncology & carcinogenesis ,Chronic Disease ,Drug Therapy, Combination ,Female ,business ,Kidney disease ,medicine.drug - Abstract
© 2019 The International Society of Dermatology, Background: Acquired perforating dermatosis (APD) comprises an uncommon group of skin disorders that develop in adulthood in association with systemic diseases. The aim of this study was to characterize clinicopathologic features and treatment outcomes in a series of patients diagnosed with APD. Methods: Retrospective study of all patients diagnosed with an APD over a 10-year period (2009-2018) at a tertiary teaching hospital in Lisbon, Portugal. Results: Fifty-seven patients with APD were identified. Thirty-five patients presented lesions in multiple anatomic areas (61.4%), and the lower limbs were the most common location. Forty-six patients reported pruritus (80.7%), which was classified as severe in 21 of them (36.8%). An underlying systemic disease was identified in 53 patients (93.0%). Diabetes mellitus (DM) and chronic kidney disease (CKD) were the most common associated systemic diseases, but psychiatric disorders, malignancies, and chronic infections were present in a significant number of patients. The combination of topical steroids with antihistamines was the most prescribed initial treatment, but only 37.8% of the patients had a complete response. Acitretin, systemic steroids, and phototherapy were the treatments associated with the best outcome. Conclusion: Acquired perforating dermatosis can be associated with many systemic disorders that have pruritus as a common factor. Chronic viral infections and an occult malignancy should be sought, particularly in the absence of DM and CKD. The management of APD is challenging and is best achieved with the control of the underlying systemic diseases.
- Published
- 2019
37. Dermatomyositis recalcitrant to treatment associated with occult malignancy
- Author
-
Farah Moustafa, Abrar A. Qureshi, Kimberly Bowerman, and Jennifer Kane
- Subjects
medicine.medical_specialty ,dermatomyositis ,Anti-nuclear antibody ,autoimmune disease ,Dermatology ,Disease ,outcomes ,Malignancy ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,case reports ,medicine ,Case Series ,Cervix ,Autoimmune disease ,clinical case ,business.industry ,Autoantibody ,Dermatomyositis ,medicine.disease ,Connective tissue disease ,CT, computed tomography ,internal medicine ,medicine.anatomical_structure ,connective tissue disease ,030220 oncology & carcinogenesis ,occult malignancy ,business - Abstract
The incidence of malignancy in patients with dermatomyositis is about 5 to 7 times greater than that of the general population.1 The most common malignancies associated with dermatomyositis include adenocarcinomas of the lung, ovaries, cervix, pancreas, and stomach.1, 2, 3, 4 Several factors have been reported as possible predictors of paraneoplastic disease, which include older age at diagnosis, male sex, autoantibodies to transcription intermediary factor 1-γ, nuclear matrix protein-2, elevated erythrocyte sedimentation rate, cutaneous necrosis, and antinuclear antibody negativity.3, 4, 5, 6, 7 In our practice, we noticed that dermatomyositis recalcitrant to therapy may be an additional predictor of underlying malignancy. We classified recalcitrant dermatomyositis as having both cutaneous and muscle disease resistant to appropriate treatment, with the exception of resistant skin disease only in an amyopathic case. Here we report 3 cases.
- Published
- 2019
38. Diabetes Mellitus and Cardiomyopathy as Presenting Features of Occult Malignant Pheochromocytoma
- Author
-
Komson Wannasai, Worapaka Manosroi, Piti Inthaphan, and Puwitch Charoenchue
- Subjects
Malignant Pheochromocytoma ,endocrine system ,medicine.medical_specialty ,reversible cardiomyopathy ,endocrine system diseases ,business.industry ,Cardiology ,Endocrinology/Diabetes/Metabolism ,General Engineering ,Cardiomyopathy ,medicine.disease ,Occult ,Gastroenterology ,Oncology ,adrenal pheochromocytoma ,Internal medicine ,Diabetes mellitus ,occult malignancy ,diabetes mellitus ,medicine ,reversible diabetes ,business - Abstract
The concomitant occurrence of diabetes mellitus and cardiomyopathy secondary to occult malignant pheochromocytoma has rarely been reported. This case report describes the case of a 48-year-old female with a previous history of diabetes mellitus, hypertension, and cardiomyopathy who presented with fatigue and significant weight loss. Neither typical symptoms of pheochromocytoma nor metastatic symptoms were presented. Pheochromocytoma with extension to the liver was incidentally found from computed tomography of the abdomen and laboratory investigations during the work-up to identify the cause for the weight loss. Right adrenalectomy and a right hepatectomy were performed. Malignant pheochromocytoma was diagnosed based on pathology. All of her underlying conditions including diabetes mellitus, hypertension, and cardiomyopathy, were improved following the complete resection of the tumor. This case emphasizes the importance of early suspicion and diagnosis of malignant pheochromocytoma in individuals with atypical presentation of a chromaffin-secreting tumor.
- Published
- 2021
39. Is it necessary to perform a morphological assessment for an esophageal motility disorder? A retrospective descriptive study
- Author
-
Cloé Charpentier, Julien Recton, Fabien Wuestenberghs, Chloé Melchior, Charlotte Desprez, Elise van der Eecken, Sabrina Sidali, Anne Marie Leroi, Olivier Touchais, Guillaume Gourcerol, Sofya Latrache, Nutrition, inflammation et dysfonctionnement de l'axe intestin-cerveau (ADEN), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institute for Research and Innovation in Biomedicine (IRIB), Normandie Université (NU)-Normandie Université (NU)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), UNIROUEN - UFR Santé (UNIROUEN UFR Santé), Normandie Université (NU)-Normandie Université (NU), Service d'Hépato-Gastroentérologie [CHU Rouen], Hôpital Charles Nicolle [Rouen]-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Normandie Université (NU), Service de physiologie digestive, urinaire, respiratoire et de l'exercice [CHU Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Hôpital Charles Nicolle [Rouen], Centre d'Investigation Clinique [CHU Rouen] (CIC Rouen), Hôpital Charles Nicolle [Rouen]-CHU Rouen, Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie, and UCL - (MGD) Service de gastro-entérologie
- Subjects
Endoscopic ultrasound ,medicine.medical_specialty ,Etiology ,Manometry ,Esophageal motility disorders ,Achalasia ,Endoscopic ultrasonography ,Endosonography ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Occult malignancy ,[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO] ,Humans ,Esophageal Motility Disorders ,Esophagogastric junction ,Tomography ,ComputingMilieux_MISCELLANEOUS ,Aged ,Retrospective Studies ,Hepatology ,medicine.diagnostic_test ,business.industry ,Gastroenterology ,Retrospective cohort study ,Middle Aged ,medicine.disease ,3. Good health ,Esophageal Achalasia ,Esophageal motility disorder ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Esophagogastric Junction ,Radiology ,business - Abstract
Background Esophageal motility disorders are most often of primary origin but may be secondary to an occult malignancy or another etiology. High-resolution esophageal manometry cannot differentiate between secondary or primary origin. This study aimed at discussing the usefulness of a morphological assessment in the diagnosis of specific esophageal motility disorders, and to establish the predictive factors of a potential secondary origin. Methods In this retrospective study, patients with suspected esophageal motility disorders who underwent an esophageal manometry were included. High-resolution manometry results were interpreted according to the Chicago Classification, 3rd version. The results of endoscopic ultrasound and computed tomography, assessed by a panel of experts, allowed to diagnose a secondary origin. Key Results Out of 2138 patients undergoing manometry, 502 patients had a esophageal motility disorder suspect to be from secondary origin; among them 182 patients underwent tomography or endoscopic ultrasound. According to experts, 16 patients (8.8%) had a secondary esophageal motility disorder: esophagogastric junction outflow obstruction (n = 7), jackhammer disorder (n = 4), achalasia (n = 3) and localized pressurization (n = 2). The etiology was malignant in 8 patients. Predictive factors suggesting potential secondary esophageal motility disorders were smoking, age ≥ 58 years and an Integrated Relaxation Pressure higher than 10 mmHg for water swallows. Conclusion and Inferences Esophageal motility disorders with organic origin are not uncommon. A morphological assessment using endoscopic ultrasonography and/or computed tomography may be of use to diagnose a secondary origin, especially in the elderly and smokers.
- Published
- 2021
40. Generalized granuloma annulare in a case of breast cancer: A case report and review of the literature
- Author
-
Ali Asilian, Mina Saber, and Roghaye Sadat Khalili Tembi
- Subjects
medicine.medical_specialty ,Medicine (General) ,Case Report ,Breast cancer ,breast cancer ,R5-920 ,Older patients ,hemic and lymphatic diseases ,medicine ,Occult malignancy ,cardiovascular diseases ,Granuloma annulare ,business.industry ,General Medicine ,medicine.disease ,equipment and supplies ,Dermatology ,granuloma annulare ,cardiovascular system ,paraneoplastic ,Medicine ,sense organs ,business ,neoplasm ,Generalized granuloma annulare - Abstract
Generalized granuloma annulare can be associated with breast cancer. Atypical granuloma annulare especially in older patients should alert physicians to the possibility of an occult malignancy.
- Published
- 2021
41. Unilateral Arm Urticaria Presenting as a Paraneoplastic Manifestation of Metachronous Bilateral Breast Cancer.
- Author
-
Kasi, Pashtoon Murtaza, Hieken, Tina J., and Haddad, Tufia C.
- Subjects
- *
URTICARIA , *BREAST cancer , *DIAGNOSIS - Abstract
Various paraneoplastic syndromes (PNS) are reported to be associated with breast cancer and can range from mild dermatological symptoms to severe neurological complications. Neurological and dermatological manifestations tend to be the more commonly seen paraneoplastic manifestations, albeit both are relatively rare. Diagnosis of the underlying malignancy is often delayed since the presence and severity of paraneoplastic manifestations are not dependent on the tumor size or stage. Herein, we describe a unique case of unilateral arm urticaria presenting as a paraneoplastic manifestation of metachronous bilateral breast cancer. Similar reports and other PNS associated with breast cancer are described. Recognition of PNS associated with underlying malignancies and age-appropriate screening can facilitate diagnosis of the underlying occult malignancy. Resection of the underlying malignancy can lead to resolution and/or improvement of the PNS for some patients. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
42. Melanoma Presenting as a Maxillary Sinus Mass: A Case Report
- Author
-
Usha Manandhar, Suraj Shrestha, Roman Dhital, Malati Dulal, Bibek Man Shrestha, Kamal Gautam, and Sansar Babu Tiwari
- Subjects
Pathology ,medicine.medical_specialty ,medicine.anatomical_structure ,Maxillary sinus ,business.industry ,Melanoma ,Mucosal melanoma ,Occult malignancy ,Medicine ,Immunohistochemistry ,business ,medicine.disease ,neoplasms - Abstract
Maxillary sinus melanoma is a rare mucosal melanoma difficult to diagnose in the absence of pigmentation. Intranasal masses presenting with the features of occult malignancy and rapid progression should always be investigated in the line of melanoma irrespective of pigmentation. The histopathological and immunohistochemical examination helps to confirm the diagnosis.
- Published
- 2021
43. Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients
- Author
-
Arnaud Bayle, C. Parisi, Antoine Italiano, Antoine Hollebecque, Loic Verlingue, Etienne Rouleau, Clémentine Sarkozy, S. Ponce, Pernelle Lavaud, Christophe Massard, F. Blanc-Durand, Mihaela Aldea, L. Cerbone, Y. Loriot, F. Mosele, M. Sakkal, Jean-Charles Soria, Ludovic Lacroix, and D. Vasseur
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Late-stage cancer ,MEDLINE ,Hematology ,Circulating Tumor DNA ,Internal medicine ,Neoplasms ,medicine ,Occult malignancy ,Biomarkers, Tumor ,Profiling (information science) ,Humans ,business - Published
- 2021
44. Trapezial Acrometastasis as the First Presentation of Occult Lung Cancer: A Case Report
- Author
-
Charlie Yoo, Leighann C. Panico, William M. Parrish, and Isaac Nivar
- Subjects
medicine.medical_specialty ,Lung Neoplasms ,Malignancy ,Squamous cell lung cancer ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Occult malignancy ,Humans ,Orthopedics and Sports Medicine ,Lung cancer ,business.industry ,HAND LESION ,Middle Aged ,medicine.disease ,Occult ,Trapezium Bone ,030220 oncology & carcinogenesis ,Carcinoma, Squamous Cell ,030211 gastroenterology & hepatology ,Surgery ,Female ,Radiology ,Differential diagnosis ,Presentation (obstetrics) ,business - Abstract
CASE Acrometastasis is extremely rare, accounting for 0.1% of all skeletal metastases. Metastases to the carpus are rarer still. This condition can be the first manifestation of an occult malignancy and generally indicates advanced disease. We present the case of a 53-year-old woman with acrometastasis of squamous cell lung cancer to the trapezium as the initial presentation of her malignancy. CONCLUSION The presentation of acrometastasis can mimic infectious or inflammatory processes, leading to an erroneous diagnosis. Although exceptionally uncommon, it is important to consider as a differential diagnosis for a destructive hand lesion.
- Published
- 2021
45. Non-Hodgkin’s Lymphoma presenting as deep venous thrombosis; A case report with literature review
- Author
-
Okba F. Ahmed, Abdulwahid M. Salih, Shvan H. Mohammed, Fahmi H. Kakamad, and Mohammed Mustafa
- Subjects
medicine.medical_specialty ,Lymphoma ,Lymphadenopathy ,Malignancy ,Article ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Occult malignancy ,cardiovascular diseases ,Lymph node ,business.industry ,Incidence (epidemiology) ,Inguinal lymphadenopathy ,medicine.disease ,Non-Hodgkin's lymphoma ,Venous thrombosis ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Deep venous thrombosis ,030211 gastroenterology & hepatology ,Surgery ,Radiology ,medicine.symptom ,business - Abstract
Highlights • DVT presentation may be an atypical manifestation of an occult malignancy. • Thorough search and work up for idiopathic DVT is mandatory. • The aim of this article is to report a case of lymphoma presented as DVT with brief literature review., Introduction Idiopathic deep venous thrombosis is a relatively common clinical finding. The aim of this article is to report and discuss a case of lymphoma presented as DVT in line with SCARE guidelines with brief literature review. Case report A 19-year-old male presented with right lower limb swelling for two week duration. Examination showed pitting leg edema with warm tense calf. Hematological investigations showed lymphopaenia. Duplex ultrasound showed DVT of right common femoral vein with inguinal lymphadenopathy. Computed tomography showed inguinal lymphadenopahthy. Histopathological examination of lymph node specimen confirmed the diagnosis of Non-Hodgkin’s Lymphoma (Burkett's type). Discussion Several series have documented a significantly higher risk of malignancy in patients with presumed idiopathic DVT. Among such patients, 7.6% have been noted to have a malignancy during follow-up; the incidence of occult malignancy diagnosed within 6–12 months of an idiopathic DVT is 2.2–5.3 times higher than that expected from general population estimates. Conclusion Idiopathic DVT regardless of age should be approached seriously with a special consideration to malignancy, lymphoma could present only with DVT.
- Published
- 2020
46. Pulmonary Adenocarcinoma Metastatic to Periocular Skin and Orbital Tissue Presenting as Orbital Cellulitis
- Author
-
Mahsa A. Sohrab, Emily Li, and John H. Sinard
- Subjects
Male ,medicine.medical_specialty ,Biopsy ,Pulmonary adenocarcinoma ,Adenocarcinoma ,03 medical and health sciences ,0302 clinical medicine ,Refractory ,Occult malignancy ,Humans ,Medicine ,Skin ,medicine.diagnostic_test ,business.industry ,Soft tissue ,General Medicine ,Middle Aged ,Orbital Cellulitis ,medicine.disease ,eye diseases ,Ophthalmology ,medicine.anatomical_structure ,030221 ophthalmology & optometry ,Surgery ,Radiology ,Orbital cellulitis ,business ,Orbital tissue ,Orbit ,Orbit (anatomy) - Abstract
A 56-year-old man presented with a periorbital subcutaneous mass and ipsilateral visually significant orbital inflammation that was refractory to broad-spectrum antibiotics. Orbitotomy with biopsy revealed the diagnosis of metastatic lung cancer, and the patient was initiated on systemic chemotherapy and adjuvant radiation. This is the first report of pulmonary adenocarcinoma metastatic simultaneously to the periocular cutaneous and intraorbital soft tissues. Atypical periorbital and orbital inflammation may be the initial presentation of occult malignancy and require a high index of suspicion and tissue biopsy for diagnosis and life-saving management.
- Published
- 2020
47. PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers
- Author
-
Gang Huang, Chensu Wang, Xiaofei Gao, Yihui Wang, Xiankai Sun, Guiyang Hao, Tian Zhao, Baran D. Sumer, Jinming Gao, Kien Nham, Woo Ping Ge, and Yahong Xiong
- Subjects
0301 basic medicine ,medicine.diagnostic_test ,Chemistry ,Biomedical Engineering ,Medicine (miscellaneous) ,Cancer ,Bioengineering ,Pet imaging ,medicine.disease ,Occult ,3. Good health ,Computer Science Applications ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Positron emission tomography ,Cancer cell ,medicine ,Cancer research ,Occult malignancy ,False positive paradox ,medicine.symptom ,030217 neurology & neurosurgery ,Biotechnology ,Acidosis - Abstract
Owing to the diversity of cancer types and the spatiotemporal heterogeneity of tumour signals, high-resolution imaging of occult malignancy is challenging. 18F-fluorodeoxyglucose positron emission tomography allows for near-universal cancer detection, yet in many clinical scenarios it is hampered by false positives. Here, we report a method for the amplification of imaging contrast in tumours via the temporal integration of the imaging signals triggered by tumour acidosis. This method exploits the catastrophic disassembly, at the acidic pH of the tumour milieu, of pH-sensitive positron-emitting neutral copolymer micelles into polycationic polymers, which are then internalized and retained by the cancer cells. Positron emission tomography imaging of the 64Cu-labelled polymers detected small occult tumours (10–20 mm3) in the brain, head, neck and breast of mice at much higher contrast than 18F-fluorodeoxyglucose, 11C-methionine and pH-insensitive 64Cu-labelled nanoparticles. We also show that the pH-sensitive probes reduce false positive detection rates in a mouse model of non-cancerous lipopolysaccharide-induced inflammation. This macromolecular strategy for integrating tumour acidosis should enable improved cancer detection, surveillance and staging. The detection of small tumours with PET is significantly enhanced by temporal integration of the imaging signals, triggered by the acidic milieu of cancers, from pH-sensitive positron-emitting polycationic polymers.
- Published
- 2019
48. 'Invisible' pancreatic masses identified by EUS by the 'ductal cutoff sign'
- Author
-
Amitpal S Johal, Kimberly J Fairley, and David L. Diehl
- Subjects
medicine.medical_specialty ,Case Report ,Lesion ,pancreatic mass ,medicine ,Pancreatic mass ,Cutoff ,Radiology, Nuclear Medicine and imaging ,fine-needle aspiration ,EUS ,Pancreatic duct ,Hepatology ,medicine.diagnostic_test ,Common bile duct ,business.industry ,Gastroenterology ,medicine.disease ,digestive system diseases ,medicine.anatomical_structure ,Fine-needle aspiration ,surgical procedures, operative ,EUS-FNA ,occult malignancy ,Tissue diagnosis ,Adenocarcinoma ,Radiology ,medicine.symptom ,business - Abstract
Making a tissue diagnosis of pancreatic adenocarcinoma is best accomplished by EUS and fine-needle aspiration (FNA) of the lesion. Typically, a dark, or "hypoechoic" mass will be seen, which presents an obvious target for FNA. For small lesions, computerized tomography (CT) may be negative, but the lesion is still almost always seen on EUS imaging. Rarely, a pancreatic mass will appear isoechoic on EUS imaging. We report three "invisible" pancreatic masses identified only by a cutoff in the pancreatic duct (PD) and/or common bile duct (CBD). No mass, isoechoic or otherwise, was seen. EUS-FNA was performed in the area of ductal narrowing, with a positive identification of adenocarcinoma in these cases.
- Published
- 2019
49. Endoscopic Ultrasound for Evaluation of Pancreatic Duct 'Cutoff' Identified on Magnetic Resonance Imaging Improves the Diagnostic Yield of Occult Malignancy
- Author
-
Frank H. Miller, Joseph Triggs, Charlotte H. Campbell, and Srinadh Komanduri
- Subjects
Endoscopic ultrasound ,Male ,medicine.medical_specialty ,Yield (engineering) ,Endocrinology, Diabetes and Metabolism ,Sensitivity and Specificity ,Endosonography ,Endocrinology ,Text mining ,Internal Medicine ,medicine ,Occult malignancy ,Cutoff ,Humans ,Endoscopic Ultrasound-Guided Fine Needle Aspiration ,Early Detection of Cancer ,Aged ,Pancreatic duct ,Hepatology ,medicine.diagnostic_test ,business.industry ,Pancreatic Ducts ,Reproducibility of Results ,Magnetic resonance imaging ,Middle Aged ,Prognosis ,Magnetic Resonance Imaging ,Pancreatic Neoplasms ,medicine.anatomical_structure ,Female ,Radiology ,business - Published
- 2021
50. Abstract P608: Risk of Cancer Following an Ischemic Stroke: A Retrospective Cohort Study From the Canadian Longitudinal Study on Aging
- Author
-
Bastien Rioux, Laura C. Gioia, and Mark R. Keezer
- Subjects
Advanced and Specialized Nursing ,medicine.medical_specialty ,Longitudinal study ,business.industry ,Cancer ,Retrospective cohort study ,medicine.disease ,Internal medicine ,Ischemic stroke ,Epidemiology ,medicine ,Occult malignancy ,Neurology (clinical) ,Stroke survivor ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background: Cancer promotes thromboembolism through inflammation and hypercoagulability, and an ischemic stroke may be the first sign of an occult malignancy. Stroke survivors may be at higher risk of incident cancer diagnosis, although the magnitude and the period at risk remain unclear. We conducted a retrospective cohort study to compare the risk of cancer in stroke survivors to that of the general population. Methods: The Canadian Longitudinal Study on Aging (CLSA) is a large, national population-based cohort of Canadian women and men aged 45-85 years when recruited between 2011 and 2015. Participants provided information on socio-demographics and prior diagnoses. We used data from the comprehensive sub-group (n=30,097) to build a retrospective cohort of participants with and without prior stroke by exact matching for age (1:4 ratio). We used log-binomial regression models to estimate the risk of cancer in people with versus without ischemic stroke while adjusting for shared risk factors. Results: We included 920 individuals in the stroke group and 3,680 individuals in the control group, respectively followed for a median of 10 (interquartile range [IQR]: 4, 17) and 11 years (IQR: 5, 19). Most inclusion events in the stroke group were minor strokes or transient ischemic attacks (n=614, 66.7%). We observed a higher incidence of cancer in the first year after stroke that declined thereafter (p=0.030). The risk of new cancer diagnosis after stroke was significantly increased (relative risk: 2.38; 95% confidence interval: 1.18, 4.63; p-value=0.012) after adjustments. The most frequent primary cancers in the first year after stroke were prostate (n=8, 57.1%) and melanoma (n=2, 14.3%). Conclusions: The risk of new cancer diagnosis in the first year after an ischemic stroke is about 2.4 times higher as compared to age-matched individuals from the general population without stroke after adjustments. Surveillance bias may explain a portion of post-stroke cancer diagnoses in the stroke group although a CLSA tendency to recruit healthier participants likely led to an underestimation of post-stroke cancer risk. Prospective experimental trials are needed to quantify the potentially pressing need to screen for post-stroke cancer.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.